EFFECT OF ORAL OFLOXACIN ON FECAL BACTERIA IN HUMAN VOLUNTEERS

被引：38

作者：

PECQUET, S ^{[1
]}

ANDREMONT, A ^{[1
]}

TANCREDE, C ^{[1
]}

机构：

[1] INST GUSTAVE ROUSSY,SERV MICROBIOL MED,ECOL MICROBIENNE LAB,F-94805 VILLEJUIF,FRANCE

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1987年 / 31卷 / 01期

关键词：

D O I：

10.1128/AAC.31.1.124

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：124 / 125

页数：2

共 13 条

[1] EFFECT OF ERYTHROMYCIN ON MICROBIAL ANTAGONISMS - A STUDY IN GNOTOBIOTIC MICE ASSOCIATED WITH A HUMAN FECAL FLORA [J].

ANDREMONT, A ;

RAIBAUD, P ;

TANCREDE, C .

JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (03) :579-587

[2] ISOLATION OF ANAEROBIC BACTERIA FROM HUMAN GINGIVA AND MOUSE CECUM BY MEANS OF A SIMPLIFIED GLOVE BOX PROCEDURE [J].

ARANKI, A ;

SYED, SA ;

KENNEDY, EB ;

FRETER, R .

APPLIED MICROBIOLOGY, 1969, 17 (04) :568-&

[3] CHANGES IN THE PHARMACOKINETICS OF CIPROFLOXACIN AND FECAL FLORA DURING ADMINISTRATION OF A 7-DAY COURSE TO HUMAN VOLUNTEERS [J].

BRUMFITT, W ;

FRANKLIN, I ;

GRADY, D ;

HAMILTONMILLER, JMT ;

ILIFFE, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :757-761

[4]

CHABBERT Y, 1957, REV FR ETUD CLIN BIO, V2, P636

[5] PHARMACOKINETIC STUDIES OF NORFLOXACIN IN LABORATORY-ANIMALS [J].

GILFILLAN, EC ;

PELAK, BA ;

BLAND, JA ;

MALATESTA, PF ;

GADEBUSCH, HH .

CHEMOTHERAPY, 1984, 30 (05) :288-296

[6] THE FLUOROQUINOLONES - PHARMACOLOGY, CLINICAL USES, AND TOXICITIES IN HUMANS [J].

HOOPER, DC ;

WOLFSON, JS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :716-721

[7] INVIVO ACTIVITY OF NIFURZIDE AND NIFUROXAZIDE IN INTESTINAL BACTERIA IN MAN AND GNOTOBIOTIC MICE [J].

LEONARD, F ;

ANDREMONT, A ;

TANCREDE, C .

JOURNAL OF APPLIED BACTERIOLOGY, 1985, 58 (06) :545-553

[8] SELECTIVE ANTIMICROBIAL MODULATION OF THE INTESTINAL-TRACT BY NORFLOXACIN IN HUMAN VOLUNTEERS AND IN GNOTOBIOTIC MICE ASSOCIATED WITH A HUMAN FECAL FLORA [J].

PECQUET, S ;

ANDREMONT, A ;

TANCREDE, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) :1047-1052

[9] INVITRO AND INVIVO ACTIVITY OF DL-8280, A NEW OXAZINE DERIVATIVE [J].

SATO, K ;

MATSUURA, Y ;

INOUE, M ;

UNE, T ;

OSADA, Y ;

OGAWA, H ;

MITSUHASHI, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) :548-553

[10] COMPARISON OF THE ANTI-BACTERIAL INVITRO AND INVIVO ACTIVITY OF OFLOXACIN (HOE-280 DL-8280) AND NALIDIXIC-ACID ANALOGS [J].

SEIBERT, G ;

LIMBERT, M ;

KLESEL, N .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (06) :548-553

← 1 2 →